POSTER SESSION IV
Tuesday, March 20, 2012 — 1:00 PM - 4:30 PM
CC Exhibit Hall B3 & C
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
HEAD & NECK PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
153
Utility of Androgen Receptor, Her-2/Neu, Cytokeratin 5/6 and p63 Immunostaining in Distinguishing Salivary Duct Carcinoma from High Grade Mucoepidermoid Carcinoma
(1285)
RT Butler, S Byrd, ME Spector, JB McHugh - University of Michigan, Ann Arbor, MI
Prognostic Features and Grading in Mucoepidermoid Carcinoma of Major Salivary Glands
(1309)
N Katabi, R Ghossein, S Ali, S Dogan, D Klimstra, I Ganly - MSKCC, New York
Expression of PAX2 and Renal Cell Carcinoma Antigen in Mucoepidermoid Carcinoma
(1341)
B Xu, RT Cheney, A Omilian, Y Liu, C Morrison - Roswell Park Cancer Institute, Buffalo, NY; State University of New York at Buffalo, Buffalo, NY
Clinicopathologic and Immunophenotypic Characterization of Six Dedifferentiated Acinic Cell Carcinomas
(1331)
JN Stall, JB McHugh - University of Michigan, Ann Arbor, MI
Sox10 Is a Novel Marker of Acinus and Intercalated Duct Differentiation in Salivary Gland Tumors
(1317)
R Ohtomo, T Mori, K Tsuta, AM Maeshima, S Yoshimoto, M Asai, H Tsuda - National Cancer Center Hospital, Tokyo, Japan
Identification of Oncogenic Mutations in Adenoid Cystic Carcinoma
(1339)
D Wetterskog, DN Rodrigues, K Fritshie, MB Lambros, S Shousha, Z Gatalica, B Weigelt, A Vincent-Salomon, G Stenman, B Rubin, JS Reis-Filho - The Institute of Cancer Research, London, United Kingdom; Cleveland Clinic, Cleveland; Charing Cross Hospital, London, United Kingdom; Creighton University School of Medicine, Omaha, United Kingdom; Cancer Research UK London Research Institute, London, United Kingdom; Institut Curie, Paris, France; Sahlgrenska Cancer Center, Gothenburg, Sweden
MYB Overexpression Associated with Advanced Stage of Adenoid Cystic Carcinoma and Together with TTF-1 Identifying Rare Lung Primary Subtype
(1342)
L Zhang, SYT Loo, D Shimizu, SA Honda, Y Cao, A Powers, M Carbone - University of Hawaii, Honolulu, HI
ALDH1 Expression and Its Significance in Adenoid Cystic Carcinoma of Salivary Glands
(1344)
JH Zhou, EY Hanna, D Roberts, RS Weber, D Bell - MD Anderson Cancer Center, Houston
Expression and Prognostic Significance of Directed Therapy Targets and Mutational Analysis of the Egfr Pathway in Malignant Salivary Gland Tumors
(1290)
JFE Cros, H Blons, E Sbidian, E Tartour, S Hans, D Brasnu, P Bruneval, C Badoual - Georges Pompidou European Hospital, Paris, France; Paris Est Creteil University, Creteil, France; INSERM - Paris Descartes University, Paris, France
Differential Expression of CyclinD1 and p16INK4A in Benign and Malignant Salivary Gland Tumors: A Study of 44 Cases
(1308)
G Jour, K West, V Ghali, G Ephrem, B Wenig - BIMC, New York, NY
Primary Signet-Ring Cell (Mucin-Producing) Adenocarcinoma of Minor Salivary Glands: A Clinicopathologic, Immunohistochemical and Molecular Survey
(1279)
JM Bastaki, BM Purgina, S Dacic, RR Seethala - University of Pittsburgh Medical Center, Pittsburgh, PA
IgG4-Related Sialadenitis Is Rare: Immunohistological Investigation of 105 Cases of Chronic Submandibular Sialadenitis
(1323)
M Rodriguez-Justo, JD Harrison - University College London Hospitals & Faculty of Biomedical Sciences UCL, London, United Kingdom; King´s College London Dental Institute, London, United Kingdom
Salivary Gland Myoepitheliomas Are Not Associated with EWSR1 Genetic Rearrangements
(1326)
AA Shah, MJ Mentrikoski, HY Scruggs, RD Legallo, HF Frierson, SE Mills, EB Stelow - University of Virginia, Charlottesville
Mucinous Myoepithelioma, a Previously Unrecognized Variant
(1297)
CJ Esteva, LJ Slater, DR Gnepp - Warren Albert Medical School of Brown University, Rhode Island Hospital, Providence, RI; Scripps Oral Pathology Service, San Diego, CA
Spectrum of Problematic Metaplastic Changes in Salivary Gland Tumors
(1300)
DR Gnepp, E Yakirevich, SK El-Mofty - Rhode Island Hospital, Providence, RI; Washington University, St. Louis, MO
Expression of Fas and FasL in Ameloblastoma and Its Different Subtypes
(1314)
F Mashhadi Abbas, S Mokhtari, H Ghorbani - Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran
EBV Prevalence in Nasopharyngeal Carcinoma
(1295)
S Dogan, SI Chiosea - Memorial Sloan-Kettering Cancer Center, New York, NY; University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh, PA
Nodular and Intravascular Fasciitis of the Lip
(1293)
WA Daraji, ELB Childers, JC Fanburg-Smith - Armed Forces Institute of Pathology, Washington, DC; Howard University, Washington, DC; Sibley Memorial Hospital of Johns Hopkins Medicine, Washington, DC
Lobular Capillary Hemangiomas of the Sinonasal Tract: Findings in a Contemporary Series with Emphasis on Recurrence
(1327)
SC Smith, RM Patel, DR Lucas, JB McHugh - University of Michigan, Ann Arbor, MI
Fibrosing Variant of Hashimoto´s Thyroiditis Is an IgG4 Related Disease
(1305)
AE Huck, WC Faquin, JH Stone, GP Nielsen, V Deshpande - Massachusetts General Hospital and Harvard Medical School, Boston, MA
Molecular Characterization of 61 Cases of Follicular Adenomas and Carcinomas of the Thyroid
(1336)
P Vielh, C Richon, G Meurice, B Job, L Lacroix, V Marthy, N Motte, A Valent, B Caillou, A Al Ghuzlan, J-M Bidart, A El Naggar, V Lazar, P Dessen, M Schlumberger - Institut Gustave Roussy, Villejuif, France; MD Anderson Cancer Center, Houston
button next to any title to add to Itinerary Planner...
Add
